Microfluidics Market by Material, Component, Application, End User

List of Tables

[183 Pages Report] The Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024, at a CAGR 25.37% to reach USD 124.31 billion by 2030.

Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.

KEY MARKET STATISTICS
Base Year [2023]	USD 25.53 billion
Estimated Year [2024]	USD 31.84 billion
Forecast Year [2030]	USD 124.31 billion
CAGR (%)	25.37%

Material: Increasing use of glass and silicon-based materials for microfluidic devices

Glass is preferred for microfluidic devices due to its excellent optical transparency properties, high chemical resistance, and biocompatibility. Polymer-based microfluidic devices offer advantages such as lower manufacturing costs, ease of fabrication through techniques, and flexibility in design. Silicon is widely used in microelectronics and is ideal for integrating sensors, actuators, and other microelectromechanical systems (MEMS) components. Silicon-based microfluidics offer advantages such as high dimensional accuracy, low surface roughness, and compatibility with standard semiconductor fabrication processes.

Component: Adoption of microneedles and pumps for minimal risk of infection

Microneedles are minimally invasive devices for various medical applications such as drug delivery, vaccination, and diagnostics. The need-based preference for microneedles is driven by painless drug administration, minimal risk of infection, and reduced tissue damage compared to traditional hypodermic needles. Micropumps are essential in microfluidics, enabling fluid transportation, metering, and mixing at the microscale. Microfluidic chips are the backbone of microfluidic systems, enabling the integration of various components to perform complex fluid manipulation tasks.

Application: Significant application of microfluidic devices in IVD and therapeutics

In-vitro diagnostics (IVD) play a crucial role in healthcare systems by providing information for disease detection, prevention, and management. Microfluidics has revolutionized IVD by enabling rapid analyses and enhanced sensitivity in diagnostic assays with its ability to manipulate small volumes of fluid. Microfluidics has immense potential to streamline pharmaceutical and life science research processes such as drug discovery, cell biology studies, genomics/proteomics analysis, and synthetic biology applications. The advantages of using microfluidic platforms are reduced reagent consumption, faster reaction times, precise control over experimental conditions, and integration of multiple functionalities on a single chip/platform. Microfluidics holds significant potential to revolutionize therapeutics through innovations in drug delivery systems, personalized medicine, regenerative medicine, and tissue engineering. The ability to specifically control fluid flow at the microscale enables the development of novel therapeutic solutions targeting specific cells or tissues, reducing side effects associated with systemic administration.

End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers

Academic institutions and research organizations rely on microfluidics to conduct biosciences, material sciences, and chemical engineering experiments. These end users require precise control over fluids, high reproducibility of results, and reduced sample volume consumption. Hospitals and diagnostic facilities benefit from microfluidic technology through point-of-care (POC) diagnostics requiring rapid analysis of biomarkers or other analytes in body fluids. Microfluidics is revolutionizing drug development and manufacturing processes within the pharmaceutical and biotechnology industries.

Regional Insights

In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Microfluidics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc., Abbott Laboratories, AbCellera Biologics Inc., Achira Labs Pvt. Ltd., Agilent Technologies, Inc., Ascent Bio-Nano Technologies, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Biosurfit SA, Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elvesys Group, Fluidigm Corporation by Standard BioTools Inc., Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Micropoint Bioscience, Inc., Mission Bio, Inc., NanoCellect Biomedical., OPKO Health, Inc., Parker-Hannifin Corporation, PerkinElmer Inc., Quidel Corporation, SMC Corporation, Sphere Fluidics Limited, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Material
- Glass-based
- Polymer-based
- Silicon-based

Component
- Micro Needle
- Micro Pump
- Microfluidic Chip

Application
- In-Vitro Diagnostics
  - Clinical Diagnostics
  - Point-Of-Care Testing
  - Veterinary Diagnostics

Pharmaceutical & Life Science Research
- Lab Analytics
  - Capillary Electrophoresis
  - Cell-based Assays
  - Genomic analysis
  - Proteomic Analysis

Microdispensing
Microreaction

Therapeutics
- Drug Delivery
- Wearable Devices

End User
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Microfluidics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microfluidics Market?

3. What are the technology trends and regulatory frameworks in the Microfluidics Market?

4. What is the market share of the leading vendors in the Microfluidics Market?

5. Which modes and strategic moves are suitable for entering the Microfluidics Market?

Product Code: MRR-036C5CF3A81A

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
  - 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
  - 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
- 5.1.2. Restraints
  - 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
- 5.1.3. Opportunities
  - 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
  - 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
- 5.1.4. Challenges
  - 5.1.4.1. Integration of Microfluidics with Existing Workflows
5.2. Market Segmentation Analysis
- 5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
- 5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
- 5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
- 5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
5.8. Client Customization

6. Microfluidics Market, by Material

6.1. Introduction
6.2. Glass-based
6.3. Polymer-based
6.4. Silicon-based

7. Microfluidics Market, by Component

7.1. Introduction
7.2. Micro Needle
7.3. Micro Pump
7.4. Microfluidic Chip

8. Microfluidics Market, by Application

8.1. Introduction
8.2. In-Vitro Diagnostics
8.3. Pharmaceutical & Life Science Research
8.4. Therapeutics

9. Microfluidics Market, by End User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Diagnostic Centers
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Microfluidics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
- 13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
- 13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio